Kadmon Holdings (Kadmon Holdings) Days Inventory : 2.41 (As of Sep. 2021)

View and export this data going back to 2016. Start your Free Trial

What is Kadmon Holdings Days Inventory?

Days Inventory is also known as Days Sales of Inventory (DSI). Kadmon Holdings's Average Total Inventories for the three months ended in Sep. 2021 was $0.02 Mil. Kadmon Holdings's Cost of Goods Sold for the three months ended in Sep. 2021 was $0.64 Mil. Hence, Kadmon Holdings's Days Inventory for the three months ended in Sep. 2021 was 2.41.

The historical rank and industry rank for Kadmon Holdings's Days Inventory or its related term are showing as below:

KDMN' s Days Inventory Range Over the Past 10 Years
Min: 13.67 Med: 253.67 Max: 338.56
Current: 13.67

During the past 7 years, Kadmon Holdings's highest Days Inventory was 338.56. The lowest was 13.67. And the median was 253.67.

KDMN's Days Inventory is not ranked
in the Biotechnology industry.
Industry Median: 192.335 vs KDMN: 13.67

Kadmon Holdings's Days Inventory declined from Sep. 2020 (18.15) to Sep. 2021 (2.41).

Inventory Turnover measures how fast the company turns over its inventory within a year. Kadmon Holdings's Inventory Turnover for the three months ended in Sep. 2021 was 37.82.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Kadmon Holdings's Inventory-to-Revenue for the three months ended in Sep. 2021 was 0.00.

Kadmon Holdings Days Inventory Historical Data

The historical data trend for Kadmon Holdings's Days Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kadmon Holdings Days Inventory Chart

Kadmon Holdings Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Days Inventory

Get a 7-Day Free Trial

255.50

131.47

301.31

221.58

67.67

Kadmon Holdings Quarterly Data
	Dec16	Mar17	Jun17	Sep17	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21
Days Inventory	Get a 7-Day Free Trial															18.15	24.41	58.93	141.02	2.41

Competitive Comparison of Kadmon Holdings's Days Inventory

For the Biotechnology subindustry, Kadmon Holdings's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Kadmon Holdings's Days Inventory Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Kadmon Holdings's Days Inventory distribution charts can be found below:

* The bar in red indicates where Kadmon Holdings's Days Inventory falls into.

Kadmon Holdings Days Inventory Calculation

Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Kadmon Holdings's Days Inventory for the fiscal year that ended in Dec. 2020 is calculated as

	Days Inventory (A: Dec. 2020 )
=	Average Total Inventories					/	Cost of Goods Sold	*	Days in Period
=	( (Total Inventories (A: Dec. 2019 )	+	Total Inventories (A: Dec. 2020 ))	/	count )	/	Cost of Goods Sold (A: Dec. 2020 )	*	Days in Period
=	( (0.64	+	0.102)	/	2 )	/	2.001	*	365
=	0.371					/	2.001	*	365
=	67.67

Kadmon Holdings's Days Inventory for the quarter that ended in Sep. 2021 is calculated as:

	Days Inventory (Q: Sep. 2021 )
=	Average Total Inventories					/	Cost of Goods Sold	*	Days in Period
=	( (Total Inventories (Q: Jun. 2021 )	+	Total Inventories (Q: Sep. 2021 ))	/	count )	/	Cost of Goods Sold (Q: Sep. 2021 )	*	Days in Period
=	( (0.012	+	0.022)	/	2 )	/	0.643	*	365 / 4
=	0.017					/	0.643	*	365 / 4
=	2.41

Kadmon Holdings (NAS:KDMN) Days Inventory Explanation

Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:

1. Inventory Turnover measures how fast the company turns over its inventory within a year.

Kadmon Holdings's Inventory Turnover for the three months ended in Sep. 2021 is calculated as

Inventory Turnover	=	Cost of Goods Sold	/	Average Total Inventories
	=	0.643	/	0.017
	=	37.82

2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Kadmon Holdings's Inventory to Revenue for the three months ended in Sep. 2021 is calculated as

Inventory-to-Revenue	=	Average Total Inventories	/	Revenue
	=	0.017	/	14.706
	=	0.00

Be Aware

A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.

Kadmon Holdings Days Inventory Related Terms

Thank you for viewing the detailed overview of Kadmon Holdings's Days Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.

Kadmon Holdings (Kadmon Holdings) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Kadmon Holdings Inc (NAS:KDMN) » Definitions » Days Inventory

Comparable Companies

Traded in Other Exchanges

N/A

Address

450 East 29th Street, New York, NY, USA, 10016

Website

https://www.kadmon.com

Kadmon Holdings Inc is a clinical-stage biopharmaceutical company engaged in the discovery, development, and commercialization of small molecules and biologics with a focus on inflammatory and fibrotic diseases. Its pipeline products include Belumosudil (KD025) and KD033.

Executives

Harlan Waksal	director, officer: President, CEO	WAKSAL CONSULTING LLC, 7 NORTH WILLOW STREET, SUITE 6, MONTCLAIR NJ 07042
Nancy Miller-rich	director	C/O INTERCEPT PHARMACEUTICALS, INC., 10 HUDSON YARDS, 37TH FL, NEW YORK NY 10001
Cynthia Schwalm	director	C/O G1 THERAPEUTICS, 700 PARK OFFICES DR, SUITE 200, P.O. BOX 110341, RESEARCH TRIANGLE PARK NC 27709
Arthur S Kirsch	director	7100 WEST CREDIT AVENUE, SUITE 101, C/O ARALEZ PHARMACEUTICALS INC., MISSISSAUGA A6 L5N 0E4
David E Cohen	director	3160 PORTER DRIVE, PALO ALTO CA 94304
Eugene Bauer	director	C/O KADMON HOLDINGS, LLC 450 E 29TH STREET NEW YORK NY 10016
Tasos Konidaris	director	103 JFK PARKWAY, SHORT HILLS NJ 07078
John L Ryan	officer: Executive Vice President, CMO	C/O KADMON HOLDINGS, LLC, 450 E. 29TH STREET, NEW YORK NY 10016
Steven Meehan	officer: EVP, Chief Financial Officer	450 E. 29TH STREET NEW YORK NY 10016
Kyle Carver	officer: Principal Accounting Officer, Controller	450 EAST 29TH STREET NEW YORK NY 10016
Gregory S. Moss	officer: EVP, General Counsel, Chief Compliance Officer	450 EAST 29TH STREET, 16TH FLOOR, NEW YORK NY 10016
Perceptive Life Sciences Master Fund Ltd	10 percent owner	C/O PERCEPTIVE ADVISORS LLC, 51 ASTOR PLACE, 10TH FLOOR, NEW YORK NY 10003
Perceptive Advisors Llc	other: Former 10% owner	51 ASTOR PLACE, 10TH FLOOR, NEW YORK NY 10003
Joseph Edelman	10 percent owner	C/O PERCEPTIVE ADVISORS LLC, 51 ASTOR PLACE, 10TH FLOOR, NEW YORK NY 10003
Steven N. Gordon	officer: Exec VP, GC, Chief Admin, Comp	C/O KADMON HOLDINGS, LLC 450 E 29TH STREET NEW YORK NY 10016